214 related articles for article (PubMed ID: 22209538)
1. Intermittent aripiprazole for schizophrenia.
Brotzge K; Manshadi M; El-Mallakh RS
Schizophr Res; 2012 Feb; 134(2-3):302-3. PubMed ID: 22209538
[No Abstract] [Full Text] [Related]
2. The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review.
Barzman DH; DelBello MP; Kowatch RA; Gernert B; Fleck DE; Pathak S; Rappaport K; Delgado SV; Campbell P; Strakowski SM
J Child Adolesc Psychopharmacol; 2004; 14(4):593-600. PubMed ID: 15662152
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients.
Centorrino F; Fogarty KV; Cimbolli P; Salvatore P; Thompson TA; Sani G; Cincotta SL; Baldessarini RJ
J Psychiatr Pract; 2005 Jul; 11(4):241-7. PubMed ID: 16041234
[TBL] [Abstract][Full Text] [Related]
4. Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M
World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247
[TBL] [Abstract][Full Text] [Related]
5. Manic episode during treatment with aripiprazole.
Padala PR; Wengel SP; Petty F
Am J Psychiatry; 2007 Jan; 164(1):172-3. PubMed ID: 17202565
[No Abstract] [Full Text] [Related]
6. Aripiprazole and depression in schizoaffective disorder.
Errico JR; Yates WR
Am J Psychiatry; 2005 Mar; 162(3):626-7. PubMed ID: 15741489
[No Abstract] [Full Text] [Related]
7. Clozapine augmentation with aripiprazole for negative symptoms.
Clarke LA; Lindenmayer JP; Kaushik S
J Clin Psychiatry; 2006 Apr; 67(4):675-6. PubMed ID: 16669737
[No Abstract] [Full Text] [Related]
8. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
[TBL] [Abstract][Full Text] [Related]
9. Treatment of psychotic disorders with aripiprazole in the emergency psychiatric setting.
Raja M; Azzoni A
Psychiatr Danub; 2008 Sep; 20(3):323-8. PubMed ID: 18827757
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
[TBL] [Abstract][Full Text] [Related]
11. Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients.
Mazza M; Squillacioti MR; Pecora RD; Janiri L; Bria P
Psychiatry Res; 2009 Jan; 165(1-2):193-6. PubMed ID: 18973955
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease.
Oulis P; Mourikis I; Konstantakopoulos G; Papageorgiou SG; Kouzoupis AV
J Neuropsychiatry Clin Neurosci; 2010; 22(3):352c.e4-352.e5. PubMed ID: 20686147
[No Abstract] [Full Text] [Related]
13. Possible increased efficacy of low-dose clozapine when combined with aripiprazole.
Lim S; Pralea C; Schnitt J; Bowers MB; Cooper C
J Clin Psychiatry; 2004 Sep; 65(9):1284-5. PubMed ID: 15367059
[No Abstract] [Full Text] [Related]
14. A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA).
Tandon R; Marcus RN; Stock EG; Riera LC; Kostic D; Pans M; McQuade RD; Nyilas M; Iwamoto T; Crandall DT
Schizophr Res; 2006 May; 84(1):77-89. PubMed ID: 16483745
[TBL] [Abstract][Full Text] [Related]
15. The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out.
Citrome L
Int J Clin Pract; 2015 Nov; 69(11):1211-20. PubMed ID: 26477545
[No Abstract] [Full Text] [Related]
16. Clozapine augmented with aripiprazole in 5 patients with schizophrenia.
Abu-Tair F; Kopitz J; Bergemann N
J Clin Psychopharmacol; 2006 Dec; 26(6):669-71. PubMed ID: 17110831
[No Abstract] [Full Text] [Related]
17. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
18. Predictors of aripiprazole treatment continuation in hospitalized patients.
Coley KC; Fabian TJ; Kim E; Ammerman DK; Scipio TM; Saul MI; Kim MS; Whitehead R; Ganguli R
J Clin Psychiatry; 2008 Sep; 69(9):1393-7. PubMed ID: 19012819
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies.
Volavka J; Czobor P; Citrome L; McQuade RD; Carson WH; Kostic D; Hardy S; Marcus R
J Clin Psychiatry; 2005 Nov; 66(11):1362-6. PubMed ID: 16420071
[TBL] [Abstract][Full Text] [Related]
20. Switching outpatients with bipolar or schizoaffective disorders and substance abuse from their current antipsychotic to aripiprazole.
Brown ES; Jeffress J; Liggin JD; Garza M; Beard L
J Clin Psychiatry; 2005 Jun; 66(6):756-60. PubMed ID: 15960570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
